Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Tarsus Pharmaceuticals | 8-K: Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Crane Rosemary A
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Andrew D.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Elizabeth Yeu
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CHAUDHURI BHASKAR
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director YARNO WENDY L
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Farrow Jeffrey S
Tarsus Pharmaceuticals | 8-K: Current report
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Andrew D.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CHAUDHURI BHASKAR
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Crane Rosemary A
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director YARNO WENDY L
No Data
No Data